Advisory Committee for Women's Services (ACWS); Notice of Meeting, 13724-13725 [2021-04935]
Download as PDF
<![CDATA[
13724
Federal Register / Vol. 86, No. 45 / Wednesday, March 10, 2021 / Notices
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Center for
Advancing Translational Sciences Special
Emphasis Panel; NCATS Conference Grants
Special Emphasis Panel.
Date: March 22, 2021.
Time: 11:00 a.m. to 2:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Center for Advancing
Translational Sciences, National Institutes of
Health, 6701 Democracy Boulevard, Room
100, Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Alumit Ishai, Ph.D.,
Scientific Review Officer, Office of Grants
Management and Scientific Review, National
Center for Advancing Translational Sciences,
National Institutes of Health, 6701
Democracy Boulevard, Suite 1000, Bethesda,
MD 20892, 301–827–5819, alumit.ishai@
nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.859, Pharmacology,
Physiology, and Biological Chemistry
Research; 93.350, B—Cooperative
Agreements; 93.859, Biomedical Research
and Research Training, National Institutes of
Health, HHS)
Dated: March 4, 2021.
David W. Freeman,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2021–04890 Filed 3–9–21; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Heart, Lung, and Blood
Institute; Notice of Closed Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
VerDate Sep<11>2014
17:22 Mar 09, 2021
Jkt 253001
Name of Committee: National Heart, Lung,
and Blood Institute Special Emphasis Panel;
NIH Support for Conferences and Scientific
Meetings.
Date: April 8, 2021.
Time: 1:00 p.m. to 5:30 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6705
Rockledge Drive, Bethesda, MD 20817
(Virtual Meeting).
Contact Person: Zhihong Shan, Ph.D., MD,
Scientific Review Officer, Office of Scientific
Review/DERA, National Heart, Lung, and
Blood Institute, (301) 827–7085,
zhihong.shan@nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.233, National Center for
Sleep Disorders Research; 93.837, Heart and
Vascular Diseases Research; 93.838, Lung
Diseases Research; 93.839, Blood Diseases
and Resources Research, National Institutes
of Health, HHS)
Dated: March 4, 2021.
David W. Freeman,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2021–04892 Filed 3–9–21; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Heart, Lung, and Blood
Institute; Notice of Closed Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Heart, Lung,
and Blood Institute Special Emphasis Panel;
Using Syndemics to Understand HLBS
Disease in People with HIV.
Date: April 16, 2021.
Time: 11:00 a.m. to 3:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6705
Rockledge Drive, Bethesda, MD 20817
(Virtual Meeting).
Contact Person: Susan Wohler Sunnarborg,
Ph.D., Scientific Review Officer, Office of
Scientific Review/DERA, National, Heart,
Lung, and Blood Institute, National Institutes
of Health, 6705 Rockledge Drive, Room 208–
PO 00000
Frm 00039
Fmt 4703
Sfmt 4703
Z, Bethesda, MD 20892, (301) 827–7987,
susan.sunnarborg@nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.233, National Center for
Sleep Disorders Research; 93.837, Heart and
Vascular Diseases Research; 93.838, Lung
Diseases Research; 93.839, Blood Diseases
and Resources Research, National Institutes
of Health, HHS)
Dated: March 4, 2021.
David W. Freeman,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2021–04889 Filed 3–9–21; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Substance Abuse and Mental Health
Services Administration
Advisory Committee for Women’s
Services (ACWS); Notice of Meeting
Pursuant to Public Law 92–463,
notice is hereby given of a meeting of
the Substance Abuse and Mental Health
Services Administration’s (SAMHSA)
Advisory Committee for Women’s
Services (ACWS) on March 31, 2021.
The meeting will include discussions
on assessing SAMHSA’s current
strategies, including the mental health
and substance use needs of the women
and girls population. Additionally, the
ACWS will be addressing priorities
regarding the impact of COVID–19 on
the behavioral health needs of women
and children and directions around
behavioral health services and access for
women and children.
The meeting is open to the public and
will be held virtually only. Interested
persons may present data, information,
or views, orally or in writing, on issues
pending before the committee. Written
submissions should be forwarded to the
contact person by March 23, 2021. Oral
presentations from the public will be
scheduled at the conclusion of the
meeting. Individuals interested in
making oral presentations are
encouraged to notify the contact person
on or before March 23, 2021. Up to five
minutes will be allotted for each
presentation.
The meeting may be accessed via
telephone or web meeting. To obtain the
call-in number and access code, submit
written or brief oral comments, or
request special accommodations for
persons with disabilities, please register
on-line at https://
snacregister.samhsa.gov/
MeetingList.aspx, or communicate with
the ACWS Designated Federal Officer,
Ms. Valerie Kolick.
E:\FR\FM\10MRN1.SGM
10MRN1
Federal Register / Vol. 86, No. 45 / Wednesday, March 10, 2021 / Notices
Substantive meeting information and
a roster of ACWS members may be
obtained either by accessing the
SAMHSA Committees’ web page at:
https://www.samhsa.gov/about-us/
advisory-councils/meetings, or by
contacting Ms. Kolick.
Committee Name: Substance Abuse
and Mental Health Services
Administration Advisory Committee for
Women’s Services (ACWS).
Date/Time/Type: Wednesday, March
31, 2021, from: 1:00 p.m. to 4:30 p.m.
EDT (OPEN).
Place: SAMHSA, 5600 Fishers Lane,
Rockville, MD 20857 (Virtual).
Contact: Valerie Kolick, Designated
Federal Officer, SAMHSA’s Advisory
Committee for Women’s Services, 5600
Fishers Lane, Rockville, MD 20857,
Telephone: (240) 276–1738, Email:
Valerie.kolick@samhsa.hhs.gov.
Dated: March 4, 2021,
Carlos Castillo,
Captain, Committee Management Officer,
Substance Abuse and Mental Health Services
Administration.
[FR Doc. 2021–04935 Filed 3–9–21; 8:45 am]
BILLING CODE 4162–20–P
DEPARTMENT OF HOMELAND
SECURITY
Federal Emergency Management
Agency
Changes in Flood Hazard
Determinations
Federal Emergency
Management Agency, Department of
Homeland Security.
ACTION: Notice.
AGENCY:
This notice lists communities
where the addition or modification of
Base Flood Elevations (BFEs), base flood
depths, Special Flood Hazard Area
(SFHA) boundaries or zone
designations, or the regulatory floodway
(hereinafter referred to as flood hazard
determinations), as shown on the Flood
Insurance Rate Maps (FIRMs), and
where applicable, in the supporting
Flood Insurance Study (FIS) reports,
prepared by the Federal Emergency
Management Agency (FEMA) for each
community, is appropriate because of
VerDate Sep<11>2014
17:22 Mar 09, 2021
Jkt 253001
These flood hazard
determinations will be finalized on the
dates listed in the table below and
revise the FIRM panels and FIS report
in effect prior to this determination for
the listed communities.
From the date of the second
publication of notification of these
changes in a newspaper of local
circulation, any person has 90 days in
which to request through the
community that the Deputy Associate
Administrator for Insurance and
Mitigation reconsider the changes. The
flood hazard determination information
may be changed during the 90-day
period.
DATES:
The affected communities
are listed in the table below. Revised
flood hazard information for each
community is available for inspection at
both the online location and the
respective community map repository
address listed in the table below.
Additionally, the current effective FIRM
and FIS report for each community are
accessible online through the FEMA
Map Service Center at https://
msc.fema.gov for comparison.
Submit comments and/or appeals to
the Chief Executive Officer of the
community as listed in the table below.
ADDRESSES:
[Docket ID FEMA–2021–0002; Internal
Agency Docket No. FEMA–B–2117]
SUMMARY:
new scientific or technical data. The
FIRM, and where applicable, portions of
the FIS report, have been revised to
reflect these flood hazard
determinations through issuance of a
Letter of Map Revision (LOMR), in
accordance with Federal Regulations.
The LOMR will be used by insurance
agents and others to calculate
appropriate flood insurance premium
rates for new buildings and the contents
of those buildings. For rating purposes,
the currently effective community
number is shown in the table below and
must be used for all new policies and
renewals.
Rick
Sacbibit, Chief, Engineering Services
Branch, Federal Insurance and
Mitigation Administration, FEMA, 400
C Street SW, Washington, DC 20472,
(202) 646–7659, or (email)
patrick.sacbibit@fema.dhs.gov; or visit
the FEMA Mapping and Insurance
eXchange (FMIX) online at https://
www.floodmaps.fema.gov/fhm/fmx_
main.html.
FOR FURTHER INFORMATION CONTACT:
PO 00000
Frm 00040
Fmt 4703
Sfmt 4703
13725
The
specific flood hazard determinations are
not described for each community in
this notice. However, the online
location and local community map
repository address where the flood
hazard determination information is
available for inspection is provided.
Any request for reconsideration of
flood hazard determinations must be
submitted to the Chief Executive Officer
of the community as listed in the table
below.
The modifications are made pursuant
to section 201 of the Flood Disaster
Protection Act of 1973, 42 U.S.C. 4105,
and are in accordance with the National
Flood Insurance Act of 1968, 42 U.S.C.
4001 et seq., and with 44 CFR part 65.
The FIRM and FIS report are the basis
of the floodplain management measures
that the community is required either to
adopt or to show evidence of having in
effect in order to qualify or remain
qualified for participation in the
National Flood Insurance Program
(NFIP).
These flood hazard determinations,
together with the floodplain
management criteria required by 44 CFR
60.3, are the minimum that are required.
They should not be construed to mean
that the community must change any
existing ordinances that are more
stringent in their floodplain
management requirements. The
community may at any time enact
stricter requirements of its own or
pursuant to policies established by other
Federal, State, or regional entities. The
flood hazard determinations are in
accordance with 44 CFR 65.4.
The affected communities are listed in
the following table. Flood hazard
determination information for each
community is available for inspection at
both the online location and the
respective community map repository
address listed in the table below.
Additionally, the current effective FIRM
and FIS report for each community are
accessible online through the FEMA
Map Service Center at https://
msc.fema.gov for comparison.
SUPPLEMENTARY INFORMATION:
(Catalog of Federal Domestic Assistance No.
97.022, ‘‘Flood Insurance.’’)
Michael M. Grimm,
Assistant Administrator for Risk
Management, Department of Homeland
Security, Federal Emergency Management
Agency.
E:\FR\FM\10MRN1.SGM
10MRN1
]]>Agencies
[Federal Register Volume 86, Number 45 (Wednesday, March 10, 2021)]
[Notices]
[Pages 13724-13725]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2021-04935]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Substance Abuse and Mental Health Services Administration
Advisory Committee for Women's Services (ACWS); Notice of Meeting
Pursuant to Public Law 92-463, notice is hereby given of a meeting
of the Substance Abuse and Mental Health Services Administration's
(SAMHSA) Advisory Committee for Women's Services (ACWS) on March 31,
2021.
The meeting will include discussions on assessing SAMHSA's current
strategies, including the mental health and substance use needs of the
women and girls population. Additionally, the ACWS will be addressing
priorities regarding the impact of COVID-19 on the behavioral health
needs of women and children and directions around behavioral health
services and access for women and children.
The meeting is open to the public and will be held virtually only.
Interested persons may present data, information, or views, orally or
in writing, on issues pending before the committee. Written submissions
should be forwarded to the contact person by March 23, 2021. Oral
presentations from the public will be scheduled at the conclusion of
the meeting. Individuals interested in making oral presentations are
encouraged to notify the contact person on or before March 23, 2021. Up
to five minutes will be allotted for each presentation.
The meeting may be accessed via telephone or web meeting. To obtain
the call-in number and access code, submit written or brief oral
comments, or request special accommodations for persons with
disabilities, please register on-line at https://snacregister.samhsa.gov/MeetingList.aspx, or communicate with the ACWS
Designated Federal Officer, Ms. Valerie Kolick.
[[Page 13725]]
Substantive meeting information and a roster of ACWS members may be
obtained either by accessing the SAMHSA Committees' web page at:
https://www.samhsa.gov/about-us/advisory-councils/meetings, or by
contacting Ms. Kolick.
Committee Name: Substance Abuse and Mental Health Services
Administration Advisory Committee for Women's Services (ACWS).
Date/Time/Type: Wednesday, March 31, 2021, from: 1:00 p.m. to 4:30
p.m. EDT (OPEN).
Place: SAMHSA, 5600 Fishers Lane, Rockville, MD 20857 (Virtual).
Contact: Valerie Kolick, Designated Federal Officer, SAMHSA's
Advisory Committee for Women's Services, 5600 Fishers Lane, Rockville,
MD 20857, Telephone: (240) 276-1738, Email:
[email protected].
Dated: March 4, 2021,
Carlos Castillo,
Captain, Committee Management Officer, Substance Abuse and Mental
Health Services Administration.
[FR Doc. 2021-04935 Filed 3-9-21; 8:45 am]
BILLING CODE 4162-20-P
